Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPRAZOLAM vs ALTEPLASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPRAZOLAM vs ALTEPLASE: Safety Overview

Metric ALPRAZOLAM ALTEPLASE
Total FAERS Reports 48,357 12,687
Deaths Reported 16,072 2,540
Death Rate 33.2% 20.0%
Hospitalizations 15,996 2,083
Average Patient Age 48.1 yrs 62.5 yrs
% Female Patients 60.4% 42.4%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Endo USA, Inc. Genentech, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription